Security key
005111109
Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)
CUSIP: 005111109
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 3,000
- Total 13F value
- $165
- Share change
- 0
- SEC-reported price per share
- $0.06
- Number of holders
- 1
- Shares outstanding
- 60,359,615
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
AFIB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Acutus Medical, Inc. SEC filings
Acutus Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 005111109
Recent filing periods:
Ownership snapshot
Top reported holders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
S.A. Mason LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
1/15
Latest evidence
30 Sep 2024
13F
3/4/5
Lead comparable stake: 0%
14 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
S.A. Mason LLC leads the comparable SEC ownership view at 0%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens S.A. Mason LLC's linked filing trail.
Comparable ownership
Top 1
S.A. Mason LLC
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| S.A. Mason LLC |
13F
Company
|
0%
|
$252
3,000 shares
|
— | 30 Sep 2024 |
| ORBIMED ADVISORS LLC |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$2,616,683
1,677,361 shares
|
— | 19 Jul 2021 |
| Shahzad Malik |
3/4/5
Director
|
—
mixed-class rows
|
$2,426,946
1,562,757 shares
mixed-class rows
|
— | 17 Jun 2021 |
| James F. Hinrichs. |
3/4/5
Director
|
—
mixed-class rows
|
$119,043
95,910 shares
mixed-class rows
|
— | 16 Jun 2022 |
| Richard Scott Huennekens |
3/4/5
Director
|
—
class O/S missing
|
$100,047
529,349 shares
|
— | 15 Jun 2023 |
| Vincent J. Burgess |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$95,892
61,469 shares
|
— | 01 Apr 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
3,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1
Q4 2024 holders
1
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend